Skip to search.
 TSX Up 0.44% TSX Ventures Up 0.66%

Novavax, Inc. (NVAX)

-NasdaqGS
11.14 Up 0.58(5.49%) 4:00PM EDT
|After Hours : 11.14 0.00 (0.00%) 4:37PM EDT
Add to Portfolio
Prev Close:10.56
Open:10.69
Bid:10.80 x 1000
Ask:11.14 x 500
1y Target Est:11.16
Beta:1.26
Earnings Date:Aug 4 - Aug 10 (Est.)
Day's Range:10.65 - 11.19
52wk Range:3.92 - 11.45
Volume:4,255,151
Avg Vol (3m):3,415,370
Market Cap:2.99B
P/E (ttm):N/A
EPS (ttm):-0.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAXUp 5.49%2.99B
MRKDown 0.63%160.84B
NVSDown 0.19%238.02B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):85.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.41
Quarterly EPS Est (Jun-15) :-0.09
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback